The purpose of the public workshop is to discuss best practices when measuring the concentration of AAV vectors and to provide FDA perspective on qualifying such assays. The public workshop will bring together academia, industry, and other stakeholders involved in research, development, and regulation of AAV-Based gene therapy products.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/37nDefu
No comments:
Post a Comment